Alkermes Submits Vivitrex NDA
Alkermes' Vivitrex would be the first alcohol dependence treatment available in a once-monthly injection if FDA approves the NDA submitted March 31
Alkermes' Vivitrex would be the first alcohol dependence treatment available in a once-monthly injection if FDA approves the NDA submitted March 31